Acquired immunodeficiency syndrome (AIDS) is a life threatening and debilitating disease state caused by retrovirus infection and the etiologic agent is now widely known as the human immunodefi ciency virus type-1. Hepatitis C Virus (HCV) causes jaundice, hepatocellular carcinoma and important viral coinfection in HIV/AIDS. Many compounds of plant origin have been identifi ed that inhibit different stages in the replication cycle of HIV [1] [2] [3] [4] . Wrightia tinctoria is an important medicinal plant used in the Indian system of medicine for the treatment of variety of diseases [5] and it to possessed analgesic [6] , cytotoxic [7] activities. Morinda citrifolia L (Noni) has been used in folk remedies by Polynesians for over 2000 years and is reported to have a broad range of therapeutic effects [8] , including antibacterial, antiviral, antifungal, antitumor, analgesic, hypotensive, antiinfl ammatory, and immune enhancing effects. The present study is designed to fi nd the antiviral activity of different extracts of Wrightia tinctoria (WT) and Morinda citrifolia (MC) against the replication of HIV-1(III B ) and Hepatitis C virus (HCV). The cytotoxicity of WT and MC is also tested against mock-infected MT-4 cells and Huh 5.2 cells.
Leaf parts of WT (Apocynaceae) were collected in and around Tenkasi, Tamilnadu, India and were dried in shade, subjected to hot continuous percolation using ether, chloroform, methanol, ethanol and water. The ether (EWT), chloroform (CWT), methanol (MWT) and ethanol (ETWT) and aqueous extracts (AWT) of WT were concentrated by distillation and used for screening. Fruit juice and powder of MC was a gift from health India laboratory, Chennai, Tamilnadu, India and the fruit powder of MC was subjected to hot continuous percolation using methanol and ethanol. The methanol (MMC) and ethanol (EMC) extract of MC were concentrated by distillation and used for screening.
Extracts of WT and MC were tested for their inhibitory effects against the replication of HIV-1(III B ) in MT-4 cells [9, 10] . The MT-4 cells were grown and maintained in RPMI 1640 Medium supplemented with 10% (v/v) heat-inactivated Fetal Calf Serum (FCS), 2 mM-glutamine, 0.1% sodium bicarbonate and 20 µg/ml gentamicin (culture medium). Inhibitory effect of extracts on HIV-1 replication was monitored by inhibition of virus-induced cytopathic effect in MT-4 cells and was estimated by MTT assay. Briefly, 50 µl of HIV-1(100-300 CCID 50 ) were added to a fl at-bottomed microtiter tray with 50 µl of medium containing various concentrations of extracts of WT. MT-4 cells were added at a final concentration of 6×10 5 cells/ml. After 5 days of incubation at 37°, the number of viable cells were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. Cytotoxicity of WT against mock-infected MT-4 cells was also assessed by the MTT method. The anti-HIV data are presented in Table 1 .
Antiviral activity against HCV in Huh 5-3 cells was undertaken with Huh-5-2 cells [10] [11] [12] (a cell line with a persistent HCV replication 1389luc-ubi-neo/NS3-3/5.1; replication with fi refl y luciferase-lubquitin-neomycine phosphotransferase fusion protein EMCV-IRES driven NS3-5B HCV polyprotein) was cultured in RPMI medium 2 mM glutamine, 1x non essential amino acid (Life Technologies, Washington DC); 100 IU/ml penicillin and 100 µg/ml streptomycin and 250 µg/ml G418 (Geneticin, Life Technologies, Washington DC). Cells were seeded at a density of 7000 cells per well in 96 well view plate TM (Packard, CA) in medium containing the same compounds as described above, except for G418. Cells were allowed to adhere and proliferate for 24 h. At that time, culture was removed and serial dilution of test compounds were added in culture medium lacking G418. Interferon α2a (500 IU) was added as a positive control. Plates were further incubated at 37º and 5% CO 2 for 72 h replication of HCV replication in Huh-5 cells results in luciferase activity in the cells. Luciferase activity was measured by adding 50 µl of 1x Glo-lysis buffer (Promega) for 15 min of followed by adding 50 µl Steady-Glo Luciferase assay reagent (promega). Luciferase activity was measured with a luminometer and signal in each individual well was expressed as a percentage of the untreated culture. Parallel culture of Huh 5-2 cells, seeded at a density of 7000 cells/well of classical 96-well cell culture plates (Becton-Dickenson) were treated in a similar fashion except that no Glo-lysis buffer or Stady-Glo Luciferase reagent was added. Instead the density of the culture was measured by means of the MTS method (Promega). The antiviral activity and cytotoxicity of the extracts are present in Table 2 .
The different extracts of WT and MC have been evaluated for antiHIV activity and cytotoxicity (Table 1) The results of antiHCV activity (Table 2) revealed that, 50% effective concentration for inhibition of HCV subgenomic replicon replication in Huh 5-2 cells (luciferase assay) by CWT was 10 µg/ml, whereas EWT and ETWT inhibits HCV RNA synthesis at the concentration (EC 50 ) of 23 and 29 µg/ml, respectively. The concentration of extracts reduced the growth of exponentially proliferating Huh 5-2 cells by 50% was greater than 50 µg/ml. MC inhibits the HCV RNA at the concentration of 0.98 µg/ml and cytotoxicity was found to be greater than 50 µg/ml.
ACKNOWLEDGEMENTS
We acknowledge A. Nijs and B. Van Remoortel for 
